Home > Riviste > Minerva Endocrinology > Fascicoli precedenti > Minerva Endocrinology 2021 September;46(3) > Minerva Endocrinology 2021 September;46(3):367-9

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi PROMO
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

LETTERS TO THE EDITOR   

Minerva Endocrinology 2021 September;46(3):367-9

DOI: 10.23736/S2724-6507.20.03163-6

Copyright © 2020 EDIZIONI MINERVA MEDICA

lingua: Inglese

Assessment of RANKL/RANK/osteoprotegerin system expression in patients with hepatocellular carcinoma

Manuela CABIATI 1, Melania GAGGINI 1, Paolo DE SIMONE 2, Giuseppina BASTA 1, Amalia GASTALDELLI 1, Silvia DEL RY 1

1 Institute of Clinical Physiology, Italian Research Council (CNR), Pisa, Italy; 2 Department of Hepatobiliary Surgery and Liver Transplantation, University of Pisa Medical School Hospital, Pisa, Italy



inizio pagina